Marksans Pharma Ltd (NSE: MARKSANS; BSE:524404) announced that it has received final approval from the US Food and Drug Administration (“FDA”) for its Abbreviated New Drug Application (“ANDA”) for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg, over the counter (“OTC”) bioequivalent of Advil Dual Action Tablets 250 mg/125 mg. The Acetaminophen and Ibuprofen Tablets, 250 …